Biotron Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.biotron.com.au

Country

Australia

Exchange

ASX

Biotron Limited, a biotechnology company develops and commercializs small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Key Stats

52-Week Range

A$0.00A$0.01

Beta-0.61

Trailing P/EN/A

Forward P/EN/A

Trailing EPS0.00

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.